Pulmonary embolism accounts for 10–15% of all paediatric venous thromboembolism (VTE) events, with an annual incidence of 0·14–0·9 per 100 000 children.1,2 Although rare, pulmonary embolism is a ...
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
Founded on July 3, 1946, SVS celebrates its legacy of supporting vascular surgeons, strengthening the specialty and ...
Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...
WHO's latest report shows that AI is already improving diagnosis, hospital efficiency and patient care across seven countries, but its success depends on strong governance, high-quality data, skilled ...
Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...
Jessica Nave, MD, vice president for middle revenue cycle at Emory Healthcare and assistant professor of medicine in Emory’s division of hospital medicine, both in Atlanta, summarized the updated 2025 ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, ...
Treatment sequencing in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains a major unmet clinical need ...
Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring ...
For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab ...
A 70-year-old woman presents to the ED with chest pain, shortness of breath and diaphoresis. Her symptoms began about 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results